Dácil Alvarado-Martel1,2, Mauro Boronat1,2, María Del Pino Alberiche-Ruano1,2, María Andrea Algara-González2, Yolanda Ramallo-Fariña3,4, Ana M Wägner1,2. 1. Endocrinology and Nutrition Department, University Hospital Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain. 2. Research Institute of Biomedical and Health Sciences (IUIBS), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain. 3. Evaluation Unit (SESCS), Canary Islands Health Research Institute Foundation (FIISC), Tenerife, Spain. 4. Research Network on Health Services in Chronic Diseases (REDISSEC), Madrid, Spain.
Abstract
Background: Type 1 diabetes is a disease with complex therapeutic recommendations that require day-to-day lifestyle changes. Motivational Interviewing is a communication tool that has proved effective in changing behaviors in people with addictions, obesity and type 2 diabetes. Our objective is to evaluate the effects of a Motivational Interviewing intervention in people with type 1 diabetes. Methods:Sixty-six patients with type 1 diabetes and hemoglobin A1c >;= 8% have been included and randomly assigned (computer-generated sequence, sealed envelopes, ratio 1:1) either to the intervention or to the control group. In the intervention group, appointments every 4 months with the endocrinologist include Motivational Interviewing; in the control group, the appointments proceed as usual. Patients will be followed for 16 months. The primary outcome will be self-care behaviors, assessed by a validated questionnaire, the Diabetes Self-Care Inventory-Revised Version. Secondary outcomes include: HbA1c, motivation for self-care, self-efficacy, health-related quality of life, satisfaction with professional-patient relationship, and fulfillment of patients' own objectives. The practitioners receive training in Motivational Interviewing in order to help them promote adherence to self-care, encourage patient motivation and improve the doctor-patient relationship. The Motivational Interviewing intervention will be evaluated by two psychologists, blinded to the assigned treatment, through video recordings of the sessions and the administration of a purpose-built questionnaire, the EVEM 2.0 scale. Discussion: There is evidence that MI can improve self-care in type 2 diabetes. In this study, we aim to evaluate the effect of MI on self-care and HbA1c in people with type 1 diabetes. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03906786, identifier NCT03906786.
RCT Entities:
Background: Type 1 diabetes is a disease with complex therapeutic recommendations that require day-to-day lifestyle changes. Motivational Interviewing is a communication tool that has proved effective in changing behaviors in people with addictions, obesity and type 2 diabetes. Our objective is to evaluate the effects of a Motivational Interviewing intervention in people with type 1 diabetes. Methods: Sixty-six patients with type 1 diabetes and hemoglobin A1c >= 8% have been included and randomly assigned (computer-generated sequence, sealed envelopes, ratio 1:1) either to the intervention or to the control group. In the intervention group, appointments every 4 months with the endocrinologist include Motivational Interviewing; in the control group, the appointments proceed as usual. Patients will be followed for 16 months. The primary outcome will be self-care behaviors, assessed by a validated questionnaire, the Diabetes Self-Care Inventory-Revised Version. Secondary outcomes include: HbA1c, motivation for self-care, self-efficacy, health-related quality of life, satisfaction with professional-patient relationship, and fulfillment of patients' own objectives. The practitioners receive training in Motivational Interviewing in order to help them promote adherence to self-care, encourage patient motivation and improve the doctor-patient relationship. The Motivational Interviewing intervention will be evaluated by two psychologists, blinded to the assigned treatment, through video recordings of the sessions and the administration of a purpose-built questionnaire, the EVEM 2.0 scale. Discussion: There is evidence that MI can improve self-care in type 2 diabetes. In this study, we aim to evaluate the effect of MI on self-care and HbA1c in people with type 1 diabetes. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03906786, identifier NCT03906786.
Authors: Manuel Campiñez Navarro; Luis Ángel Pérula de Torres; Josep M Bosch Fontcuberta; Nieves Barragán Brun; Juan Carlos Arbonies Ortiz; Jesús Manuel Novo Rodríguez; Julia Bóveda Fontán; Remedios Martín Alvarez; Jose Antonio Prados Castillejo; Gabriela Renée Rivas Doutreleau; Carmen Domingo Peña; Jaime Jesús Castro Moreno; Esperanza María Romero Rodríguez Journal: Eur J Gen Pract Date: 2016-06-07 Impact factor: 1.904
Authors: Yu-Chi Wang; Sunita M Stewart; Marsha Mackenzie; Paul A Nakonezny; Deidre Edwards; Perrin C White Journal: Diabetes Care Date: 2010-05-18 Impact factor: 17.152
Authors: Dácil Alvarado-Martel; M Angeles Ruiz Fernández; Maribel Cuadrado Vigaray; Armando Carrillo; Mauro Boronat; Ana Expósito Montesdeoca; Lía Nattero Chávez; Maite Pozuelo Sánchez; Pino López Quevedo; Ana D Santana Suárez; Natalia Hillman; David Subias; Pilar Martin Vaquero; Lourdes Sáez de Ibarra; Didac Mauricio; Pedro de Pablos-Velasco; Francisco J Nóvoa; Ana M Wägner Journal: Front Psychol Date: 2017-05-31